Treatment of allergy to mushrooms;Tratamiento de la alergia a hongos

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue SUPPL. 2, 2003, Pages 129-137

  Lizaso Bacaicoa, M T ^a   Garcia B E ^b   Gomez B ^b   Zabalegui, A ^b   Rodriguez M J ^b   Tabar, A I ^b  

^a Seccion de Alergologia   (Spain)

^b NONE

Author keywords

Allergy; Alternaria; Immunotherapy; Mushrooms

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; PLANT EXTRACT;

ALLERGIC RHINITIS; ALTERNARIA; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL STRATEGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; ENVIRONMENTAL MANAGEMENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LUNG FUNCTION; MAINTENANCE DRUG DOSE; MAXIMUM TOLERATED DOSE; MUSHROOM; OUTCOMES RESEARCH; RESPIRATORY TRACT ALLERGY; REVIEW; SIDE EFFECT; SYMPTOM;

ADOLESCENT; ALTERNARIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; RESPIRATORY HYPERSENSITIVITY;

EID: 0041817734     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. D'AMATO G, CHATZIGEORGIOU G, CORSICO R, GIOULEKAS D, JÄGER L, JÄGER S, et al. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. EEACI Position Paper. Allergy 1997; 52: 711-716.
2. D'AMATO G, SPIEKSMA FTM. Aerobiologic and clinical aspects of mould allergy in Europe. EAACI Position Paper. Allergy 1995; 50:870-877.
3. SALVAGGIO J, AUKRUST L. Mold-induced asthma. J Allergy Clin Immunol 1981; 68: 327-346.
4. PÉREZ SANTOS C, MORENO AG. En: Hongos y alergia. Madrid: Dome/Hollister-Stier. 1992: 93.
5. SLY RM. New guidelines for diagnosis and management of asthma. Ann Allergy Asthma Immunol 1997; 78: 427-437.
6. VAN CAUWENBERGE P, BACHERT C, PASSALACQUA G, BOUSQUET J, CANONICA GW, DURHAM SR et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000; 55: 116-134.
7. BOUSQUET J, LOCKEY RF, Malling HG. WHO Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 53: 1-42.
8. ABRAMSON MJ, PUY RM, WEINER JM. Is allergen immunotherapy effective in asthma? Am J Respir Crit Care Med 1995; 151: 969-975.
9. ABRAMSON MJ, PUY RM, WEINER JM. Immunotherapy in asthma: an updated systematic reviw. Allergy 1999; 54: 1022-1041.
10. MALLING HJ, WEEKE B. EAACI Immunotherapy Subcommittee. Position Paper: Immunotherapy. Allergy 1993; 48: 1-45.
11. KAAD PH, OSTERGAARD PA. The hazard of mould hyposensitization in children with asthma. Clin Allergy 1982; 12: 317-320.
12. OSTERGAARD PA, KAAD PH, KRISTENSEN T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy 1986; 41: 588-593.
13. DREBORG S, AGRELL B, FOUCARD T, KJELLMAN M, KOIVIKKO A, NILSSON S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladospurium herbarum preparation. 1. Clinical results. Allergy 1986, 41: 131-140.
14. MARTORELL A, SOLE A, DIEZ LV, BELENGUER J, SANZ J, TORRO MI et al. Inmunoterapia en alergia a hongos. Rev Esp Alergol Inmunol Clin 1986; 1: 188-192.
15. MALLING HJ, DREBORG S, WEEKE B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41: 507-519.
16. CANTANI A, BUSINCO E, MAGLIO A. Alternaria allergy: A three-year controlled study in children treated with immunotherapy. Allergol et immunopathol 1988; 16: 1-4
17. HORST M, HEJJAOUI A, HORST V, MICHEL B, BOUSQUET J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990; 85: 460-72.
18. TABAR AI, LIZASO MT, GARCÍA BE, ECHECHIPÍA S, OLAGUIBEL JM, RODRÍGUEZ A. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial astma. J Investig Allergol Clin Immunol 2000; 10: 327-333.
19. LOMBARDERO M, GONZALEZ R, DUFFORT O, JUAN F, AYUSO R, VENTAS P et al. Evaluación de la actividad biológica total y composición alergénica de extrtactos alergénicos. Allergol Immunopathol19986; 14: 189-198.
20. TURKELTAUB PC. Biological standardization of allergenic extracts. Allergol Immunopathol 1989; 17: 53-65.
21. EAACI Subcommittee on Skin tests. Allergen standardization and skin tests. Position Paper. Allergy 1993; 48: 48-82.
22. JUNIPER EF, GUYATT GH, EPSTEIN RS, FERRIE PJ, JAESCHKE R, HILLER TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
23. SANJUAS C, ALONSO J, SANCHIS J, CASAN P, BROQUETAS JM, FERRIE PJ et al. The quality of life questionnaire with asthma patients; the Spanish version of the Asthma Quality of Life Questionnaire. Archiv Bonconeumol 1995; 31: 219-226.
24. AAS K. Heterogeneity of bronchial asthma. Allergy 1981; 36: 3-14.
25. MELTZER EO. Evaluating rhinitis: clinical, rhinomanometric and cytologic assessments. J Allergy Clin Immunol 1988; 82: 900-908.
26. MÖLLER CH, BJÖRKSTEN B, BNILSSON G, DREBORG S. The precision of the bronchial provocation test. Allergy 1984; 39: 37-41.
27. HIRST JM. An automatic volometric spore trap. Ann Appl Biol 1952; 39: 257-265.
28. CHAPMAN MD. Environmental allergen monitoring and control. Allergy 1998; 53: 48-53.